Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
March 28, 2018 08:30 ET
|
Vitality Biopharma, Inc
THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter
March 19, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100
January 17, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
January 03, 2018 08:30 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals
November 01, 2017 07:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Nov 1, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD
October 19, 2017 07:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 19, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Announces Publication of International PCT Patent Filing for Cannabinoid Pharmaceuticals
October 16, 2017 07:00 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 16, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough
October 04, 2017 07:30 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 4, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40
September 27, 2017 11:07 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Sep 27, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma to Present at The MoneyShow San Francisco Conference
August 23, 2017 08:47 ET
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Aug 23, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid...